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Abstract
BACKGROUND & AIMS—Identification of intestinal stem cells (ISCs) has relied heavily on
the use of transgenic reporters in mice, but this approach is limited by mosaic expression patterns
and difficult to directly apply to human tissues. We sought to identify reliable surface markers of
ISCs and establish a robust functional assay to characterize ISCs from mouse and human tissues.
METHODS—We used immunohistochemistry, real-time reverse-transcription polymerase chain
reaction, and fluorescence-activated cell sorting (FACS) to analyze intestinal epithelial cells
isolated from mouse and human intestinal tissues. We compared different combinations of surface
markers among ISCs isolated based on expression of Lgr5–green fluorescent protein. We
developed a culture protocol to facilitate the identification of functional ISCs from mice and then
tested the assay with human intestinal crypts and putative ISCs.
RESULTS—CD44+CD24loCD166+ cells, isolated by FACS from mouse small intestine and
colon, expressed high levels of stem cell–associated genes. Transit-amplifying cells and progenitor
cells were then excluded based on expression of GRP78 or c-Kit. CD44+CD24loCD166+
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GRP78lo/− putative stem cells from mouse small intestine included Lgr5-GFPhi and Lgr5-
GFPmed/lo cells. Incubation of these cells with the GSK inhibitor CHIR99021 and the E-cadherin
stabilizer Thiazovivin resulted in colony formation by 25% to 30% of single-sorted ISCs.
CONCLUSIONS—We developed a culture protocol to identify putative ISCs from mouse and
human tissues based on cell surface markers. CD44+CD24loCD166+, GRP78lo/−, and c-Kit−
facilitated identification of putative stem cells from the mouse small intestine and colon,
respectively. CD44+CD24−/loCD166+ also identified putative human ISCs. These findings will
facilitate functional studies of mouse and human ISCs.
Keywords
Stemness; Differentiation; Single-Cell Sorting; Flow Cytometry Analysis
The intestinal epithelium offers an elegant model for studying mammalian adult stem cells
because of its simple structure and high turnover rate. In vivo genetic marking, coupled with
lineage tracing, is a reliable approach for characterizing mouse intestinal stem cells (ISCs);
however, this method depends on transgenic or knock-in animal models such as Lgr5–green
fluorescent protein (GFP) to identify crypt base columnar (CBC) cells and reporter
constructs for Bmi-1, mTert, Hopx, and Lrig1 to mark +4 ISCs.1–6 In addition, these
transgenic reporter mice often display mosaic expression; more importantly, their use in
isolating these populations cannot be translated directly to human studies.
Several groups have reported sorting ISCs using single surface markers, including EphB2,
CD24, and CD166.7–9 However, the common caveat is that a single surface marker is unable
to effectively exclude progenitor and differentiated cells. For example, EphB2 is broadly
expressed in >60% of human crypt cells at variable levels, but even EphBhi cells contain
both ISCs and Muc2+ progenitor cells.7 The expression of Sox9-GFP or CD24+ was used to
isolate ISCs but revealed only 0.2% to 0.6% colony-forming efficiency (CFE)10; therefore,
neither of these molecules alone can serve as a robust ISC biomarker.
Functional analysis is required to verify candidate markers for sorted ISCs. However, robust
survival of ISCs using the reported in vitro culture method is dependent on Paneth cells
(PCs).11,12 Although Wnt3a was reported to replace PCs in this in vitro culture system,12
there are controversial reports that single Lgr5+ CBCs can efficiently grow only when mixed
with PCs, not with the addition of Wnt3a.13 Furthermore, the colon does not have PCs, and
c-Kit+ goblet cells may support the growth of colonic stem cells (CoSCs) but with very low
efficiency.14 These data highlight the need to develop a robust in vitro culture method for
ISC studies.
Currently, 2 subpopulations of ISCs have been reported to regulate tissue homeostasis:
CBCs with rapidly cycling properties intermingled among PCs and quiescent ISCs located
above the PC zone near the +4 position.1–3,15–17 Although CBCs were reported to also
express all the +4 ISC markers,18 recent in vivo studies have shown that after genetic
ablation or radiation damage, a reserve ISC population located above the PC zone is
activated to regenerate the damaged epithelium.4,6,19,20 Despite this important finding, no
surface markers are available to efficiently isolate either of the ISC populations.
In this study, we identified a combination of surface markers for isolating mouse ISCs with
different Lgr5 expression levels, which were functionally characterized using a newly
developed culture method. This method also improves culture of either human crypt or
fluorescence-activated cell sorting (FACS)-isolated single human ISCs.
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Mice and Human Tissues
The Lgr5–enhanced GFP mouse model was provided by Hans Clevers. Adult mice (6–12
weeks old) were used in all experiments. All mice were housed in the animal facility at
Stowers Institute for Medical Research and handled according to Stowers Institute for
Medical Research and National Institutes of Health guidelines. All procedures were
approved by the Institutional Animal Care and Use Committee of Stowers Institute for
Medical Research. Use of human tissues was approved by the institutional review board at
Cincinnati Children’s Hospital Medical Research Center and by an institutional review
board–exempt protocol at University of California, Los Angeles.
Histological Analysis of Tissue
Mouse intestinal tissue was fixed in 1× zinc formalin. The fixed tissues were embedded in
paraffin and processed as previously described.21
Mouse Intestinal Crypt Isolation and Cell Dissociation
For information on mouse intestinal crypt isolation and cell dissociation, see Supplementary
Materials and Methods.
Cell Culture
Sorted cells were collected at low temperature, pelleted, and embedded in Growth Factor
Reduced Matrigel (BD Biosciences, San Jose, CA), followed by seeding on a prewarmed
96-well plate (~200 to 300 single cells in 8.5–10 μL Matrigel per well). Matrigel contained
750 ng/mL epidermal growth factor (Peprotech), 1.5 μg/mL Noggin (Peprotech, Rocky Hill,
NJ), and 15 μmol/L Jagged-1 (Anaspec, Fremont, CA). Prewarmed seeding media (100 μL)
was added after full polymerization of Matrigel. Seeding medium was Advanced Dulbecco’s
modified Eagle medium/F12, supplemented with penicillin (100 U/mL)/streptomycin (100
μg/mL), Glutamax, 10 mmol/L HEPES, 1× N2, 1× B27 (all from Invitrogen, Carlsbad, CA),
1 mmol/L N-acetylcysteine (Sigma St. Louis, MO), Thiazovivin (2.5 μmol/L; Sheng Ding
Lab, San Francisco, CA), and CHIR99021 (2.5 μmol/L; Stemgent, Cambridge, MA).
Growth factors containing 1 μg/mL R-Spondin 1 (R&D Systems, Minneapolis, MN), 1
μmol/L Jagged-1 peptide (Anaspec), 50 ng/mL epidermal growth factor (Invitrogen), and
100 ng/mL Noggin at final concentration were added on day 2 after cell seeding.11 The first
media change was processed on day 4 by removing 50% and adding 50% freshly prepared
Advanced Dulbecco’s modified Eagle medium/F12, supplemented with penicillin/
streptomycin, Glutamax, HEPES, 2× N2, 2× B27, 2 μg/mL R-Spondin 1, 100 ng/mL
epidermal growth factor, and 200 ng/mL Noggin. The culture was then maintained regularly
by adding growth factors without Jagged-1 every other day and then changing the entire
medium every 4 days. The same strategy was used for single colonic ISC culture. FGF4
(200 ng/mL; R&D Systems) can be added during the first 8 days but is not essential for
colony formation.
Flow Cytometric Analysis
Cells (2–6 × 106/mL) were stained with antibodies (Supplementary Materials and Methods)
for 30 minutes at 4°C followed by secondary antibody staining for another 30 minutes. After
washing, cells were analyzed by MoFlo (DakoCytomation, Carpinteria, CA). Cell size gate,
based on forward scatter and side scatter, was set up first to exclude cell debris and clumps;
the other gates were set as shown in Figure 1. Flow cytometry data collection and cell
sorting were performed with a MoFlo Legacy Cell Sorter (Beckman Coulter, Indianapolis,
IN) (see details in Supplementary Materials and Methods). Postsort analysis of cells
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confirmed successful sorting of desired populations at high purity (Supplementary Figure 6).
Data analysis was performed using FlowJo (Tree Star Inc, Ashland, OR).
Measurement of CFE
When seeding the sorted cells in Matrigel for culture, we fixed and stained 3 to 4 wells with
4′,6-diamidino-2-phenylindole to count the initial number of seeding cells as the
denominator. The average number of enteroids formed from the remaining 4 to 7 wells
served as the numerator.
Quantitative Reverse-Transcription Polymerase Chain Reaction
TaqMan gene expression assays (Applied Biosystems, Foster City, CA) were performed on
triplicate samples (Supplementary Materials and Methods). Data were normalized relative to
3 reference genes: GUSB, TBP, and Hprt1.22 Ct values were calculated to obtain fold
changes for sample comparison (DataAssist v3.0, Applied Biosystems, Foster City, CA).
Statistical Analysis
Data are represented as mean ± SEM. Two-tailed Student t test was used to determine
statistical significance for bar charts or pairwise comparisons with a significance cutoff of P
< .05.
Results
A Combination of Antibodies to CD44, CD24, and CD166 Purified Putative ISCs by
Excluding Differentiated Cells From the Villus and Crypt
We used a general strategy to enrich ISCs and to exclude differentiated cells with a
combination of positive and negative markers, respectively (Figure 1A). Besides confirming
a broad crypt-restricted CD44 expression (Figure 1B), we further found that CD44
expression was higher at the interface between 2 adjacent Lgr5-GFPhi CBCs than that
between 2 adjacent PCs (Figure 1C and Supplementary Figures 1 and 3). Furthermore, 2
additional ISC surface markers, CD24 and CD166 (ALCAM),8–10 were highly expressed in
the lower region of crypts where ISCs are located (Figure 1D). Together, these data suggest
that CD44 can be used to select intestinal epithelial crypt cells, including ISCs, and that
CD24 and CD166 can be further used to exclude transient-amplifying and some progenitor
cells.
Using FACS, we performed sequential doublets via pulse-width gating, dead/apoptotic cells
using 7-aminoactinomycin D plus annexin V, and blood cells with CD45 staining (Figure
1E). We also found that more than 97% of live CD45− cells were EpCAM+ cells, an
epithelial cell marker, and thereby eliminated the need to incorporate EpCAM into our
procedure (Supplementary Figure 2). After the purification of CD44+ crypt cells, we further
applied CD24 and CD166 gating to cosegregate the cells into 4 subpopulations based on
isotype staining (Figure 1E and Supplementary Figure 1). To determine the cellular
composition of these subpopulations, we then used reverse-transcription polymerase chain
reaction (RT-PCR) to measure expression levels of stem cells and differentiation markers
(Figure 1F) using the total unfractioned live intestinal epithelial cells (IECs) as the reference
population.
Among these 4 groups (Figure 1F), the high expression of stem cell–associated genes in the
CD44+CD24loCD166med population and the low expression of differentiation genes in the
CD44+CD24loCD166lo population indicated the identification of putative ISCs with
different Lgr5 expression levels in these 2 gates. The combination of CD166 and CD24
staining revealed a CD24lo subpopulation with a more distinctive boundary compared with
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CD24 alone (Supplementary Figure 4). Thus, we combined CD44+CD24loCD166lo and
CD44+CD24loCD166med populations to define the CD44+CD24loCD166+(lo+med)
population that was used for further purifying ISCs.
The CD44+CD24−CD166lo population revealed the lowest expression of stem cell–related
genes (Figure 1F, columns 1–3). On the other hand, the CD44+CD24hiCD166+
subpopulation expressed a high level of secretory lineage markers but a low level of Ki67
expression (Figure 1F, columns 10–12), indicating that this population was enriched for
secretory cells. Using immunostaining of Ki67, we confirmed the quantitative RT-PCR
(qRT-PCR) results (Supplementary Figures 5 and 6). In addition, a previous study reported
that a combination of side scatter and CD24 can separate CD24hi cells into 2 subpopulations
that respectively select endocrine cells and PCs.12,13 Interestingly, the CD24hiCD166hi cells
derived from the CD44− population also fell into the “PC” gate (Supplementary Figures 1
and 3), providing a potential method to analyze and sort heterogeneous secretory lineage
cells.
GRP78+ and GRP78−/lo Distinguished Progenitor Cells and Stem Cells, Respectively
To further exclude remaining differentiated cells from the CD44+CD24loCD166+
population, we tested other candidate surface markers, including the 78-kilodalton glucose-
regulated protein (GRP78) (Figure 2A).23 We found that GRP78 was expressed at the
highest level in the villus (differentiated cell zone), at an intermediate level in the upper
crypt (transient-amplifying cell zone), and at the lowest level in the lower crypt, thus
negatively selecting for the majority of ISCs (Figure 2B). A combination of GRP78 and
CD44 formed 3 subpopulations of cells defined as CD44−GRP78+, CD44loGRP78+, and
CD44hiGRP78−/lo (Figure 2C). qRT-PCR gene expression analysis showed that the
CD44hiGRP78−/lo and CD44loGRP78+ populations, respectively, expressed the highest level
and lowest level of ISC-related genes, indicating that the combination of GRP78 and CD44
can largely distinguish ISCs from progenitor cells (Figure 2D).
However, CD44+GRP78−/lo could not efficiently exclude CD24hi differentiated cells
(Supplementary Figure 7), so we combined GRP78 with the previously identified
CD44+CD24loCD166+ population (Figure 2E). qRT-PCR assay showed that
CD44+CD24loCD166+GRP78−/lo cells expressed higher levels (10-fold) of active ISC-
related genes (Lgr5 and Ascl2) but lower levels of differentiation markers (ChgA, Alpi, and
Muc2) than did CD44+CD24loCD166+ GRP78+ cells (Figure 2F). Taken together, these data
indicate that inclusion of GRP78−/lo expression facilitates further purifying ISCs from the
CD44+CD24loCD166+ subpopulation. Interestingly, these 2 subpopulations express Lrig1
and Hopx, 2 reserve ISC-related genes, at similar levels, consistent with a recent report.18
CD44hiCD24loCD166+c-Kit− Combinatorial Markers Identified Putative CoSCs
To purify CoSCs, we applied a strategy similar to that used for ISCs (Figure 3A). CD44
immunostaining revealed a gradient expression in the colonic crypt, with the highest level in
the putative CoSC zone of the crypt base1 (Figure 3B). Consistently, a clear separation of
CD44hi, CD44med, and CD44−/lo subpopulations could be attained by flow cytometry
(Figure 3C). Similar to a reported ISC marker EphB2hi,24 CD44hi can identify cells at the
crypt base, including Lgr5+ stem cells, adjacent goblet cells, and Lgr5GFPlo cells (Figure
3B, arrows). Therefore, additional markers are required to exclude progenitor cells from
CD44hi cells.
Immunostaining of colonic tissues showed that CD24hi cells localized mainly in the lower
crypt, where they overlapped with some Muc2+ goblet cells (Figure 3B), whereas CD166
demonstrated a broader expression along the entire crypt axis (Figure 3B). With the addition
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of CD24 and CD166, the CD44hi population could be further separated into 3
subpopulations by flow cytometry: CD24loCD166lo, CD24loCD166hi, and
CD24hiCD166med (Figure 3C). Compared with CD24hiCD166med cells, CD24loCD166lo/hi
populations expressed a high level of stem cell–related genes and a low level of the goblet
cell gene Muc2 (Figure 3E). We also found that EphB2 was expressed at similar levels in
these populations (Figure 3E), indicating its inability to distinguish CoSCs from neighboring
Muc2+ goblet cells.
Because we failed to detect GRP78 expression in the colon, we used c-Kit14 to negatively
select Muc2+ cells (Figure 3B). Thus, CD44hiCD24loCD166+ cells could be further divided
into c-Kit+ and c-Kit− populations by flow cytometry (Figure 3C). RT-PCR analysis
revealed that CD44hiCD24loCD166+c-Kit− cells expressed a 5-fold higher level of Lgr5 and
Ascl2 and a much lower level of Muc2 (Figure 3F). In addition, the combination of
CD44hic-Kit− could exclude largely differentiated cells; however, it still contained a small
portion of CD24hi cells (recognizing secretory cells) (Supplementary Figure 8). Taken
together, these data show that, although the combined markers CD44hic-Kit− can largely
purify for CoSCs by FACS, a more pure population can be defined by
CD44hiCD24loCD166+cKit−.
Inhibition of GSK3β and Stabilization of E-cadherin Enable Robust Colony Formation for
Testing Single Stem Cells
Characterizing single cells isolated using cell surface markers requires a robust functional
assay. However, the current assay achieved only very low CFE even when supplementing
the current medium with Wnt3a and other reported factors11 (Figure 4A and Supplementary
Figure 9). This is consistent with a recent report that Wnt3a cannot replace PCs to support
efficient in vitro colony formation from single ISCs.13 We showed that Wnt3a conditional
medium, containing myriad unknown factors, could only modestly increase the CFE of
single ISCs (Supplementary Figure 10). However, a high frequency of cell death occurred
during the first 4 days of culture, indicating that additional signaling pathways besides Wnt
are essential for survival of ISCs.
CHIR99021, a GSK3β inhibitor, can efficiently activate β-catenin and potential other
survival pathways. It has been effectively used for in vitro culture of embryonic25 and
hematopoietic stem cells.26 We found that only a low dose of CHIR99021 (2.5 μmol/L)
during the first 2 days of culture (Figure 4A) enabled the survival of and subsequent robust
growth of single Lgr5-GFPhi ISCs (Figure 4C and Supplementary Figures 9 and 10),
whereas a high dose (5–10 μmol/L) inhibited colony growth (Supplementary Figure 11).
Thiazovivin has been reported to increase the stability of E-cadherin and inhibit Rock
activity,27 both of which are essential to reduce apoptosis and support survival of single
cells during the first 2 days of culture. In our hands, Thiazovivin was more effective than the
Rock inhibitor Y27632, as shown with either bigger colony sizes (Supplementary Figure 10)
or higher CFE (see Materials and Methods for accurate measurement of CFE). With use of
both CHIR99021 and Thiazovivin, we could increase the CFE of single Lgr5GFPhi ISCs up
to 25% to 30% (Figure 4A).
We next used the same strategy for CoSC culture and observed formation of colonoids from
single CoSCs28 (Figure 4D). We observed 2 types of colonoid structures during the growth
of Lgr5GFPhi colonies: a closed form similar to enteroids and an open form with a typical
colon-like polarized morphology (Figure 4E). We also observed that the closed form could
transform into an open form as the colony grew (Supplementary Figure 12). These colonoids
contained both Lgr5-GFP+ stem cells (Figure 4E) and differentiated cells, as revealed by
electron microscopy analysis and immunostaining (Figure 4F). Taken together, our work
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supports the establishment of a robust culture system to evaluate stemness of sorted ISCs
and CoSCs.
Combinatorial Cell Surface Markers Show Purification of Functional ISCs and CoSCs
Using the robust single-cell culture method, we measured the extent of ISC enrichment by
our surface marker combination. We first used Lgr5-GFPhi ISCs as the reference to evaluate
sorted cells for ISC identification. Given the mosaic expression of Lgr5-GFP, an increase in
the percentage of Lgr5-GFPhi cells from 7.1% of the unfractioned live cells to 24.2% of the
CD44+CD24loCD166+GRP78−/lo population is significant (Figure 5A). Consistently, with
each additional antibody applied to our population (from CD44+ to CD44+CD24loCD166+
and to CD44+CD24loCD166+ GRP78−/lo cells), we observed an increase in CFE (Figure
5B). The latter population revealed a CFE similar to that of FACS-isolated Lgr5-GFPhi cells
from the transgenic reporter mouse (P = .42, t test, 2 tailed, Figure 5B); thus, we showed that
the combination of CD44+CD24loCD166+ GRP78−/lo surface markers enriched for ISCs to a
similar degree as the best available genetic reporter line. Although the
CD44+CD24loCD166+ GRP78+ population could cover more than 82% of total Lgr5-GFPhi
cells, as measured by backgating analysis (Supplementary Figure 13), the RT-PCR result
revealed that it still contained a minor portion of ChgA-expressing endocrine cells (Figure
5C).
We next measured the enrichment of CoSCs isolated using our surface marker combination.
A similar increase in the percentage of Lgr5-GFPhi cells was observed in colon cells and
reached about 17% in CD44+CD24loCD166+c-Kit− cells (Figure 5D). Accordingly, the CFE
and gene profiling of CD44+CD24loCD166+c-Kit– cells was similar to that of Lgr5-GFPhi
cells (Figure 5E and F).
CD44+CD24loCD166+ GRP78−/lo Identifies Putative ISCs Independent of Lgr5-GFPhi Cells
One significant limitation of using the Lgr5-GFP reporter mouse line to label stem cells is
the mosaic pattern of GFP+ crypts (Figure 6A). Consistently, we found that the Lgr5
expression level in the CD44+CD24loCD166+ GRP78− population isolated from Lgr5-
GFPneg crypts was 50% that of Lgr5-GFPhi cells (Figure 6C), indicating that this population
included the genuine Lgr5hiCBC cells. Also, the Lgr5-GFPneg cells had a CFE (>90%)
similar to that of Lgr5-GFPhi cells (Figure 6D), indicating that the CD44+CD24loCD166+
GRP78−/lo markers enabled sorting putative ISCs from Lgr5-GFPneg crypts, independent of
Lgr5-GFP reporter.
Different GFP expression levels in the Lgr5-GFP+ crypts (Figure 6A) were reported to
faithfully reflect the endogenous Lgr5 expression levels and to distinguish CBC cells and
progenitor cells.18,29 Derived from the CD44+CD24loCD166+GRP78−/lo population, Lgr5-
GFPlo/med and Lgr5-GFPhi subpopulations had an average CFE of 19% and 27%,
respectively (Figure 6C and D). In contrast, Lgr5-GFPlo/med cells within the
CD44+CD24loCD166+GRP78+ gate barely formed colonies (data not shown). Recent
studies confined the high level of Lgr5 expression to the PC zone, while Olfm4 and Ascl2
showed broader expression in both CBC and +4 position.18,30 Similarly, we also detected
that expression levels of Olfm4 and Ascl2 in the Lgr5-GFPlo/med population were
approximately 40% that of the Lgr5-GFPhi population, consistent with the notion that Lgr5-
GFPlo/med cells are most likely located at the +4 position above the CBC zone. Thus, based
on the gene expression signature and CFE tests of these 2 different subpopulations, we
concluded that within the Lgr5-GFP–positive crypts, not all colony-forming cells were
derived from Lgr5-GFPhi cells. Some Lgr5-GFPlo/med cells located mainly above the CBC-
PC zone (Figure 6A) were capable of forming enteroids.
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We then asked whether Lgr5-GFPlo/med and Lgr5-GFPneg cells identified by surface markers
could give rise to Lgr5-GFPhi enteroids. We showed that while the Lgr5-GFPneg cells gave
rise mainly to Lgr5-GFPneg enteroids, the Lgr5-GFPlo/med cells could generate new
enteroids containing Lgr5-GFPhi cells (Figure 6E and F). Compared with Lgr5-GFPhi ISC-
derived enteroids, Lgr5-GFPlo/med ISC-derived enteroids shared similar expression levels of
Lgr5, Ascl2, and other differentiated cell markers. Both groups can be maintained long-term
in vitro (Supplementary Figure 14). Taken together, these results provide new evidence for
putative ISCs located above the PC zone, consistent with the recently reported
interconversion between ISC populations residing in distinct zones of the crypt.4,6,31 It was
recently reported that Dll1+CD24med cells could generate enteroids with 1% CFE under high
doses of Wnt ligand32; however, our CD24lo sorted cells could largely exclude Dll1+ cells
and the corresponding CFE was much higher (20%–30%).
The New Culture Strategy Could Be Translated to Human Intestinal Tissue
The current barrier in translating mouse studies into human tissue has been the low
efficiency of culture of human small intestinal crypts and the difficulty of long-term in vitro
maintenance. We tested the culture method that we developed in mice on human small
intestinal tissue. Adding CHIR99021 (2.5 μmol/L) and other reported factors33 during the
first 2 days increased the efficiency of enterosphere formation (Figure 7A and B). The
enterospheres underwent extensive budding to give rise to enteroids after 4 days and could
be maintained over 3 months (Figure 7C). After withdrawing Wnt3a factor,33 the major
differentiated cell types could be detected in the human enteroids (Figure 7D).
We further applied our culture method to surface marker–mediated FACS-isolated single
human intestinal cells. We found that CD44+CD166+CD24lo cells could identify IECs
expressing stem cell markers (Supplementary Figure 15). However, we also noted that
adding CD166 and GRP78 did not distinguish distinctive subpopulations as observed in
mouse intestinal tissue. Furthermore, we found that the level of CD24 expression varied
from proximal (high) to distal (low) regions of human intestine (data not shown). Finally,
our data indicated that the addition of the GSK inhibitor, instead of other reported factors,33
enhanced colony formation from single CD44+CD166+CD24lo cells but that the efficiency
was not more than 1% (Supplementary Figure 15). Taken together, our proposed surface
marker paradigm and culture method provide a strong foundation for continued optimization
for isolation and characterization of human ISCs.
Discussion
Identification of highly purified functional ISCs is required for understanding their
properties and for translational studies using human ISCs. Using transgenic reporters to
isolate ISCs has several limitations. (1) The mosaic expression pattern of the reporter gene
results in an inability to distinguish a truly negative population. (2) Direct application of
these studies to the human system is difficult. (3) A single reporter could exclude important
ISC subpopulations. Progress in other stem cell systems, particularly the hematopoietic
system, which depended on the use of multiple, combinatorial cell surface markers to
identify different hematopoietic stem cell subsets, is being applied to basic and clinical
research. The study presented here will begin alleviating these deficiencies in the ISC field.
Our study showed that differentiated cells and progenitor cells share many reported single
markers such as CD24, CD166, and EphB2hi with ISCs (Figures 1 and 3).9,12 Similar to the
hematopoietic system, multiple cell surface marker combinations were shown to be essential
for the effective exclusion of differentiated cells. We systemically tested combinations of
new as well as previously reported cell surface markers by gene profiling and functional
assays. We also tested a new strategy to exclude villous cells using antibody B6A6, which
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recognizes most villous cells except goblet cells (Supplementary Figure 16). The new
marker GRP78 showed the ability to separate ISCs from progenitor cells when combined
with markers CD44, CD24, and CD166. For human tissue, however, additional markers will
be required to further exclude differentiated cells from the CD44+CD24loCD166+
population. Upon completion of this work, a new anti-Lgr5 antibody recognizing
overexpressed Lgr5 in cancer cell lines was reported.34,35 This antibody should solve the
problem of mosaic expression patterns in the transgenic reporter line; however, whether
Lgr5hi versus Lgr5med/lo can be distinguished using this antibody is unknown.
Previously reported high CFE of ISCs depended on coculturing with niche cells, which
cannot be replaced by exogenous Wnt3a.13 Similarly, a recent report indicated that
constitutive activation of the Wnt pathway by deletion of Apc in Lgr5-GFPhi cells still led to
only a 0.6% CFE.36 Here, we showed that transient application of the GSK-3β inhibitor
CHIR99021 instead of Wnt3a and R-Spondin promoted the survival of single ISCs during
the first 2 days, suggesting that antiapoptotic pathways are activated downstream of GSK-3β
inhibition. Moreover, compared with Y27632, the E-cadherin stabilizer Thiazovivin also
supported higher CFE, and this may be due to decreasing anoikis by improved E-cadherin
stabilization. This new culture protocol is also applicable to human ISCs, emphasizing its
clinical relevance.
Despite being a valuable tool, overreliance on single-gene reporters may result in failure to
recognize the complexity of different ISC subsets. Benefiting from the Lgr5-GFP mice, we
unexpectedly found that the Lgr5-GFPlo/med cells within the Lgr5-GFP–positive crypts
isolated from GRP78−/lo but not from GRP78+ of the CD44+CD24loCD166+ subpopulation
could also efficiently form enteroids. This observation indicates that our surface markers can
select enteroid-forming Lgr5lo/med cells outside the PC zone, supporting the existence of a
non-Lgr5hi ISC population. In addition, the low CD24 expression and high CFE of these
cells indicate that they are different from recently reported Dll1+CD24med progenitors,
which have very low CFE.32
In summary, we showed that CD44+CD24loCD166+ plus GRP78lo/− or c-Kit− identifies
putative ISCs and CoSCs in mice. These surface marker combinations and the clonal assay,
in principle, can be applied to the human system, which will be critical for future clinical
application.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Combination of CD44, CD24, and CD166 preliminarily excludes small intestinal
differentiated cells. (A) Experimental scheme of excluding villus and crypt differentiated
cells. (B) Immunohistochemistry (IHC) staining shows gradient expression of CD44 in
crypts but not in villi. (C) Confocal cross section of crypt bottom, showing strong staining of
CD44 (bright blue) in the junctions of Lgr5-GFPhi stem cells (green, arrowheads) and weak
staining between PCs (red, arrows). (D) IHC staining of CD24 and CD166 (green) shows
higher expression at the crypt base. (E) FACS strategy for sequentially gating single cells,
live IECs, CD44+ cells, and cells with different CD24 and CD166 expression. (F) qRT-PCR
analysis showing the stem cell and differentiation marker expression in 4 subpopulations
gated from CD44+ cells versus total live IECs by heat map (left) and column chart (right).
Data are presented as mean ± SEM (n = 3). Scale bars = 50 μm (B and D); 20 μm (C).
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GRP78 excludes progenitors in the CD44+ CD24loCD166+ population. (A) Experimental
scheme of excluding progenitor and differentiated cells from CD44, CD24, and CD166 cells
using GRP78+. (B) IHC staining shows high expression of GRP78 (red) in the villi and
upper crypt but low expression in the stem cell zone at the crypt base. (C) Single live IECs
divided into 3 subgates of CD44hiGRP78−/lo, CD44lo GRP78+, and CD44− GRP78+. (D)
Heat map of qRT-PCR results shows the gene expression relative to single live IECs in 3
subgates (C) (n = 2). (E) Two subgates of CD44+CD24loCD166+GRP78−/lo and
CD44+CD24loCD166+GRP78+. (F) Heat map of qRT-PCR results shows the gene
expression profiling in CD44+CD24loCD166+GRP78−/lo cells relative to the
CD44+CD24loCD166+GRP78+ population (n = 3). Scale bars = 50 μm (B).
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CD44, CD24, CD166, c-Kit combination identifies CoSCs. (A) Experimental scheme of
gradually purifying colonic ISCs. (B) IHC staining shows expression pattern of CD44,
CD24, CD166, and c-Kit in colon. The cross section shows the expression of CD44 (white)
in Muc2+ (red) cells adjacent to Lgr5-GFPhi (green) cells (arrowheads) and in the
conjunction of Lgr5-GFPlo cells (arrows). (C) Sequential FACS plots and gates as indicated.
(D) qRT-PCR results show gene expression in the CD44med and CD44hi cells versus
CD44lo/− cells (n = 2). (E) Gene expression in CD44hiCD24loCD166lo and
CD44hiCD24loCD166hi populations relative to the CD44hiCD24hiCD166med population
(E)and further separation with c-Kit (F) (n = 3). Scale bars = 50 μm (B); 10 μm (B,
magnification).
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Small molecules enable robust culturing of bona fide single ISCs or CoSCs. (A) Strategies
to culture single Lgr5-GFPhi cells and comparison of Wnt3a and CHIR99021 have an
impact on CFE. Data are presented as mean ± SEM (P = .0004, t test, n = 3). (B) IHC
staining shows the differentiated cell type in the enteroid derived from single ISCs. (C)
Representative images recording the process of single Lgr5-GFPhi cell–forming enteroids.
(D) A growth process from a single Lgr5-GFPhi CoSC into colonoid. (E) An open colonoid
structure derived from a single Lgr5-GFPhi CSC. AF, autofluorescence. (F) Colonoids
containing differentiated cell types identified by electron microscopic analysis. Scale bars =
50 μm (B); 100 μm (C, D, E); 4 μm (F).
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The surface marker combination identifies the ISC population with CFE comparable to that
of Lgr5-GFPhi cells. (A) Lgr5-GFPhi cells in parent gates were largely confined in daughter
gates, showing the gradual selection by surface marker combination. (B) CFE analysis of
different subpopulations. Data are presented as mean ± SEM, (*P < .05, **P < .01, n = 4, t
test). (C) The gene profiling of CD44+CD24loCD166+ GRP78−/lo cells, taking Lgr5-GFPhi
ISCs as control (n = 3). (D) Colonic Lgr5-GFPhi cells in parent gates were largely confined
in daughter gates, showing the gradual purification by surface marker combination. (E) CFE
analysis of series of gates. Data are presented as mean ± SEM (*P < .05, **P < .01, n = 4, t
test). (F) The gene profiling of CD44hiCD24loCD166+cKit− cells, taking Lgr5-GFPhi CoSCs
as control (n = 3).
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CD44+CD24loCD166+ GRP78−/lo identifies ISCs independent of Lgr5-GFPhi cells. (A) The
mosaic distribution of Lgr5-GFP+ crypt in jejunum. Gradient GFP expression in Lgr5-GFP+
crypt. (B) Lgr5-GFPneg, Lgr5-GFPlo/med, and Lgr5-GFPhi gates in the
CD44+CD24loCD166+ GRP78−/lo population. (C) qRT-PCR results show the gene
expression of Lgr5-GFPneg and Lgr5-GFPhi cells relative to Lgr5-GFPlo/med cells from the
CD44+CD24loCD166+ GRP78−/lo population. Data are presented as mean ± SEM (n = 4, *P
< .05, **P < .01, ***P < .001). (D) CFE analysis of the Lgr5-GFPneg, Lgr5-GFPlo/med, and
Lgr5-GFPhi cells in the gates of B. Data are represented as mean ± SEM (*P < .05, n = 3, t
test). (E) A growth process of single cells sorted from Lgr5-GFPneg, Lgr5-GFPlo/med, and
Lgr5-GFPhi gates in B, showing that Lgr5-GFPlo/med cells can generate Lgr5-GFPhi
enteroid. (F) FACS analysis of enteroids derived from single Lgr5-GFPneg, Lgr5-GFPlo/med,
and Lgr5-GFPhi cells, showing that single Lgr5-GFPlo/med cells can generate enteroids
containing Lgr5-GFPhi cells as single Lgr5-GFPhi cells did. Data are presented as mean ±
SEM (n = 3, **P < .01).
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The new culture strategy enables highly efficient human crypt culture and maintenance. (A)
Crypt culture strategy. CHIR99021 significantly increased the efficiency of culturing human
small intestinal crypts. Data are presented as mean ± SEM (n = 6, *P .011, t test). (B)
Representative growth process of human small intestinal crypt culture with addition of a
single dose of GSK inhibitor CHIR99021 and other factors.33 (C) Human enteroid can be
passaged up to 10 times over a 3-month period, as shown by their growth after passaging
from day 0 to day 7. (D) IHC staining show the cellular proliferation and differentiated cell
types in cultured enteroid. Positive staining is indicated by the arrow in the inset. Scale bars
= 200 μm (B and C); 50 μm (D).
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